Calcitonin0 vendors competing
No vendor pricing available for this peptide yet.
Research details
Calcitonin — research data
Regulatory statusFDA-approved (Miacalcin)
NCAA D1Not listed
Overview
About Calcitonin
Mechanism of action
Inhibits osteoclast-mediated bone resorption; reduces serum calcium
Safety profile
Nasal irritation, rhinitis, back pain; possible malignancy signal · Long history of use; nasal irritation; slight cancer signal led to EMA re-evaluation but still available
Related pages
